Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07775833 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Study Protocol: The Efficacy of Mushroom to Reduce Cognitive Decline in At-Risk Middle-aged Adults and Young-olds Living in the Community

StatusRecruiting
PhaseNot applicable
Started2026-10
View on ClinicalTrials.gov ↗

Amendment history

2026-08-28
Study Status, Outcome Measures v1
Secondary endpointsdetails revised at 1 of 7 entries
2026-08-18
Original filing
The investigator's objective is to explore the definitive evidence of mushroom on cognitive functions among at-risk middle-aged and young-olds. The investigator carefully designed a randomized controlled trial (RCT) to assess the role of mushrooms in promoting cognitive functioning among around 600 middle-aged adults and young-olds. Participants were selected based on specific inclusion criteria, such as being community-living adults aged 45-80 years with a family history of dementia or subjective cognitive decline, while consuming mushrooms no more than once a week and having no dementia, along with the exclusion of individuals with neurological or psychiatric disorders and significant sensory or motor impairments. Participants in the intervention group will consume Pleurotus citrinopileatus mushroom powder daily for 24months, with compliance
Trial Details
NCT Number NCT07775833
Lead Sponsor National University of Singapore
Conditions Dementia, Cognitive Assessment
Enrollment 600 participants
Start Date 2026-10
Primary Completion 2028-12 (estimated)
Study Completion 2030-12 (estimated)
Updated on ClinicalTrials.gov 2026-09-01